Asston Pharmaceuticals IPO Subscription.
SME
Asston Pharmaceuticals: Category QIB offered 4,25,000 shares, applied 3,64,49,000 shares, with a subscription of 85.76x, and total amount raised is 448.32 Cr. Category HNI offered 3,22,000 shares, applied 11,38,26,000 shares, with a subscription of 353.50x, and total amount raised is 1,400.06 Cr. Category BHNI (9+ Lots) offered 2,14,667 shares, applied 9,12,62,000 shares, with a subscription of 425.13x, and total amount raised is 1,122.52 Cr. Category SHNI (3 - 8 Lots) offered 1,07,333 shares, applied 2,25,64,000 shares, with a subscription of 210.22x, and total amount raised is 277.54 Cr. Category Individual Investor (2 Lots) offered 7,46,000 shares, applied 12,84,16,000 shares, with a subscription of 172.14x, and total amount raised is 1,579.52 Cr. Category Total offered 14,93,000 shares, applied 27,86,91,000 shares, with a subscription of 186.67x, and total amount raised is 3,427.90 Cr.
Asston Pharmaceuticals: For QIB, - shares were reserved, max winners were -, 62 were applied, application-wise subscription was -, and people-based subscription was -. For BHNI (9+ Lots), 213 shares were reserved, max winners were 71, 8,616 were applied, application-wise subscription was 40.45x, and people-based subscription was 121x. For SHNI (3 - 8 Lots), 108 shares were reserved, max winners were 36, 6,457 were applied, application-wise subscription was 59.79x, and people-based subscription was 179x. For Individual Investor (2 Lots), 746 shares were reserved, max winners were 373, 64,208 were applied, application-wise subscription was 86.07x, and people-based subscription was 172x. Total applications received were 79,343.
| Category | Offered | Applied | Times | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| QIB | 4,25,000 | 3,64,49,000 | 85.76x | 448.32 |
| HNI | 3,22,000 | 11,38,26,000 | 353.50x | 1,400.06 |
| BHNI (9+ Lots) | 2,14,667 | 9,12,62,000 | 425.13x | 1,122.52 |
| SHNI (3 - 8 Lots) | 1,07,333 | 2,25,64,000 | 210.22x | 277.54 |
| Individual Investor (2 Lots) | 7,46,000 | 12,84,16,000 | 172.14x | 1,579.52 |
| Total | 14,93,000 | 27,86,91,000 | 186.67x | 3,427.90 |
Last Updated : 11 Jul, 2025 05:55:54 PM
| Category | Reserved | Max Winners | Applied | Times (Application Wise) | Actual Times (People Based) |
|---|---|---|---|---|---|
| QIB | - | - | 62 | - | - |
| BHNI (9+ Lots) | 213 | 71 | 8,616 | 40.45x | 121x |
| SHNI (3 - 8 Lots) | 108 | 36 | 6,457 | 59.79x | 179x |
| Individual Investor (2 Lots) | 746 | 373 | 64,208 | 86.07x | 172x |
Total Applications: 79343
IPO Investor Categories
- Qualified Institutional Buyers (QIB)
Institutions like banks, mutual funds, insurance companies, and other SEBI-registered entities fall under the QIB category. They typically invest large sums on behalf of clients or schemes. - Non-Institutional Investors (NII)
This group includes high-net-worth individuals (HNIs), NRIs, trusts, and companies that apply for shares worth more than ₹2 lakhs. Unlike QIBs, SEBI registration is not required.NII is further split into:
- sNII (Applications below ₹10 Lakhs)
Investors bidding between ₹2 lakhs and ₹10 lakhs fall in the Small NII (sHNI) bracket. One-third of the NII portion is set aside for them. - bNII (Applications above ₹10 Lakhs)
Investors applying for more than ₹10 lakhs are classified as Big NIIs (bHNI). Two-thirds of the NII shares are allocated to this sub-category.
- sNII (Applications below ₹10 Lakhs)
- Retail Individual Investors (RII)
Individuals or NRIs applying for shares up to ₹2 lakhs are considered retail investors and are part of the RII quota. - Employee (EMP)
This section is reserved for eligible employees of the company participating in the IPO. - Others
Includes eligible shareholders or specific investors with a reserved quota as per the IPO policy.
Read more about Asston Pharmaceuticals IPO
Disclaimer: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites. The information / data provided herein is for informational purposes only and is provided by a2zipo.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. a2zipo.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites. a2zipo.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. a2zipo.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites. The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.